» Articles » PMID: 34215617

Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development

Overview
Journal Cancer Res
Specialty Oncology
Date 2021 Jul 3
PMID 34215617
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Meningiomas are the most common benign brain tumors. Mutations of the E3 ubiquitin ligase TRAF7 occur in 25% of meningiomas and commonly cooccur with mutations in KLF4, yet the functional link between TRAF7 and KLF4 mutations remains unclear. By generating an meningioma model derived from primary meningeal cells, we elucidated the cooperative interactions that promote meningioma development. By integrating TRAF7-driven ubiquitinome and proteome alterations in meningeal cells and the TRAF7 interactome, we identified TRAF7 as a proteostatic regulator of RAS-related small GTPases. Meningioma-associated TRAF7 mutations disrupted either its catalytic activity or its interaction with RAS GTPases. TRAF7 loss in meningeal cells altered actin dynamics and promoted anchorage-independent growth by inducing CDC42 and RAS signaling. TRAF deficiency-driven activation of the RAS/MAPK pathway promoted KLF4-dependent transcription that led to upregulation of the tumor-suppressive Semaphorin pathway, a negative regulator of small GTPases. KLF4 loss of function disrupted this negative feedback loop and enhanced mutant TRAF7-mediated cell transformation. Overall, this study provides new mechanistic insights into meningioma development, which could lead to novel treatment strategies. SIGNIFICANCE: The intricate molecular cross-talk between the ubiquitin ligase TRAF7 and the transcription factor KLF4 provides a first step toward the identification of new therapies for patients with meningioma.

Citing Articles

Role of Mutation in the Development of Eleven Different Cancers.

Hosseingholi Nouri S, Nitturi V, Ledbetter E, English C, Lau S, Klisch T Cancers (Basel). 2025; 17(1.

PMID: 39796693 PMC: 11720051. DOI: 10.3390/cancers17010064.


Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma.

Wen Y, Wang H, Yang X, Zhu Y, Li M, Ma X Nat Commun. 2024; 15(1):10088.

PMID: 39572526 PMC: 11582648. DOI: 10.1038/s41467-024-54140-1.


Expression of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Candidate Genes , , and in Normal Human Kidney Development and CAKUT.

Kelam J, Kelam N, Filipovic N, Komic L, Racetin A, Komic D Genes (Basel). 2024; 15(6).

PMID: 38927638 PMC: 11203332. DOI: 10.3390/genes15060702.


K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins.

Magits W, Steklov M, Jang H, Sewduth R, Florentin A, Lechat B EMBO J. 2024; 43(14):2862-2877.

PMID: 38858602 PMC: 11251195. DOI: 10.1038/s44318-024-00146-w.


Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome.

Thirimanne H, Almiron-Bonnin D, Nuechterlein N, Arora S, Jensen M, Parada C Cell Genom. 2024; 4(6):100566.

PMID: 38788713 PMC: 11228955. DOI: 10.1016/j.xgen.2024.100566.